Safety of oral ibandronate in the treatment of bone metastases from breast cancer : long-term follow-up experience.
McLachlan
Sue-Anne
SA
St Vincent's Hospital, Melbourne, Victoria, Australia. Sue.Anne.MCLACHLAN@svhm.org.au
Cameron
David
D
Murray
Robin
R
Tripathy
Debu
D
Bergström
Bengt
B
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D003404:Creatinine / Q000097:blood; D004164:Diphosphonates / Q000009:adverse effects*; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D000077557:Ibandronic Acid; D007668:Kidney / Q000187:drug effects; D008875:Middle Aged
D004164:Diphosphonates; D003404:Creatinine; D000077557:Ibandronic Acid